Drugs / Saffron
Saffron
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT06413238 | Jun → Dec 2024 | diabetes mellitus | Fateme Moshirenia | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT05117749 | May 2023 → Feb 2025 | ulcerative colitis | Shiraz University of Medical Sciences | Unknown | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT07054697 | Jan 2017 → Dec 2024 | autism spectrum disorder | Aditi Chadha | Completed | No outcome recorded |
| Phase 4 | NCT07161804 | Dec 2016 → Dec 2024 | autism spectrum disorder | Holistic Homoeopathic Clinic and Research Center | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05696665 | Jul 2022 → Jul 2023 | Parkinson disease, neurodegenerative disease | Jinnah Postgraduate Medical Centre | Unknown | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT05715099 Comparator | Mar → May 2023 | ulcerative colitis | Minia University | Unknown | No outcome recorded |
| Phase 4 | NCT01625442 Comparator | Jan 2010 → Jul 2011 | hyperglycemia, hyperlipoproteinemia, hypertriglyceridemia, metabolic syndrome X | Birjand University of Medical Sciences | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Saffron | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05696665 ↗ |
| Known as | Crocus sativus | “Thuja officinalis Vaccininum Causticum Argentum nitricum Tuberculinum Stramonium Staphysagria Arum triphyllum Bacillinum Cina Carcinocin Cuprum Metallicum Ambera grisea...” NCT07161804 ↗1“CROCUS SATIVUS” NCT07054697 ↗ |
| Known as | Crocus sativus L. | “Saffron, Crocus sativus L., is widely used as spice and medicine with anti-obesity, anticonvulsant, anti-hyperlipidemic, anti-tumor, antioxidant, and anti-inflammatory properties.” NCT05117749 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Emerging alternative medicine worldwide led investigators to evaluate the efficacy of Crocus sativus (Saffron) and Berberis Vulgaris (barberry fruit) in treatment of metabolic syndrome.” NCT01625442 ↗ |